Clinical Trial Update: Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence [Phase 2]

View source ↗

Summary

Phase 2 study evaluating FluGlucoScan (F-fluorodeoxyglucose) in patients with known or suspected cancers; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Multiple Myeloma
• Ovarian Cancer
• Sarcoma
• Testicular Cancer

Drugs mentioned

• FluGlucoScan (fluorodeoxyglucose)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Sarcoma, Multiple Myeloma | Phase 2 | Status: COMPLETED